Open Menu
The Defender Children’s Health Defense News and Views
Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Advocacy
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD

    • Condiciones de salud

    rfk jr presidential announcement feature
    covid wuhan lab leak senate report feature
    covid vaccine adverse events deaths feature
    covid vaccine injury claims feature
    chd nih lawsuit foia covid vaccine injury feature
    united states government covid vaccine spending feature
    bbc astrazeneca covid vaccine feature
    doctors incentive covid vaccine feature
    switzerland covid vaccine feature
    world vaccine congress feature
    Días antes de la publicación prevista para hoy de una serie de documentos relacionados con la vacuna COVID de Pfizer, la empresa farmacéutica pidió a un tribunal federal que le permitiera intervenir antes de que se publicara cualquier información.
    andre cherry moderna vaccine injury feature
    covid vaccines injuries closed door feature
    covid vaccine death damage feature
    healthy kid teen covid vaccine feature
    faa pilot medical clearance feature
    faa pilot medical clearance myocarditis feature
    mary holland speech covid court feature
    federal covid vaccine mandate blocked feature
    rand paul stephane bancel moderna feature
    anthony fauci covid vaccines feature
    twitter files virality project feature
    fda fourth covid vaccine infants kids feature
    death surge kids teens feature
    germany covid vaccine injuries feature
    uk lockdown files covid vaccine feature
    cdc covid vaccine grant feature
    declassify covid origins feature